DBM Global delivers robust revenue growth, reinforcing market leadership -- Life Sciences: MediBeacon received regulatory ...

Discover why Greenfire Resources offers long-term value despite dilution fears—robust Q3 results, growth plans, and ...

The findings of this study support the routine use of sodium-glucose cotransporter 2 (SGLT2) inhibitors to improve kidney outcomes ...

To address knowledge gaps, investigators conducted a meta-analysis of more than 70,000 patients in 10 trials of SGLT2 inhibitors vs placebo to determine the relative risks of CKD progression across ...

The phase 2 EXPLORE-CKD trial is examining the efficacy and safety of lorundrostat in addition to SGLT2 inhibitors in patients with hypertension and CKD with albuminuria.

The current kidney transplant waitlistingcriterion is based on a single measurement of kidney function (estimated glomerular ...

Expanding the wait-listing criteria for kidney transplantation to include risk for kidney failure -- rather than taking a ...

HOUSTON -- Two commonly used kidney function tests had a large degree of disagreement and were linked with serious health ...

The current kidney transplant waitlisting criterion is based on a single measurement of kidney function (estimated glomerular ...

Investigators assessed the independent associations of albuminuria and eGFR with overall and site-specific cancers using data from more than one million patients in the Chronic Kidney Disease ...

Enrollment ongoing in Phase 2 KOURAGE trial of Auxora in acute kidney injury (AKI) with respiratory failure; data expected in 1H 2026 Positive discussions with FDA ...

Balcinrenone is similar to finerenone (Kerendia), which is also a nonsteroidal MRA and was approved for the slowing of ...